Literature DB >> 34876668

Choosing drugs for UK COVID-19 treatment trials.

Patrick F Chinnery, Marion Bonnet, Alison Cave, Matthias P Hofer, Alastair Lamb, Glenn A McConkey, Nicholas Medcalf, Stephen P Smith, Teresa Tsakok, Robert Watson, Steve Webster, Tao You.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 34876668     DOI： 10.1038/d41573-021-00203-7

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  3 in total

1.  Glucocorticoid sensitivity and proinflammatory cytokines pattern in pemphigus.

Authors:  Rosangela Soares Chriguer; Ana Maria Roselino; Margaret de Castro
Journal:  J Clin Immunol       Date:  2012-03-10       Impact factor: 8.317

2.  The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro.

Authors:  Xi Wang; Ruiyuan Cao; Huanyu Zhang; Jia Liu; Mingyue Xu; Hengrui Hu; Yufeng Li; Lei Zhao; Wei Li; Xiulian Sun; Xinglou Yang; Zhengli Shi; Fei Deng; Zhihong Hu; Wu Zhong; Manli Wang
Journal:  Cell Discov       Date:  2020-05-02       Impact factor: 10.849

3.  Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing.

Authors:  Laura Riva; Shuofeng Yuan; Xin Yin; Laura Martin-Sancho; Naoko Matsunaga; Lars Pache; Sebastian Burgstaller-Muehlbacher; Paul D De Jesus; Peter Teriete; Mitchell V Hull; Max W Chang; Jasper Fuk-Woo Chan; Jianli Cao; Vincent Kwok-Man Poon; Kristina M Herbert; Kuoyuan Cheng; Tu-Trinh H Nguyen; Andrey Rubanov; Yuan Pu; Courtney Nguyen; Angela Choi; Raveen Rathnasinghe; Michael Schotsaert; Lisa Miorin; Marion Dejosez; Thomas P Zwaka; Ko-Yung Sit; Luis Martinez-Sobrido; Wen-Chun Liu; Kris M White; Mackenzie E Chapman; Emma K Lendy; Richard J Glynne; Randy Albrecht; Eytan Ruppin; Andrew D Mesecar; Jeffrey R Johnson; Christopher Benner; Ren Sun; Peter G Schultz; Andrew I Su; Adolfo García-Sastre; Arnab K Chatterjee; Kwok-Yung Yuen; Sumit K Chanda
Journal:  Nature       Date:  2020-07-24       Impact factor: 69.504
  3 in total
  1 in total

1.  Early-phase clinical trials in a pandemic: learning from the response to COVID-19.

Authors:  Alex Horsley; Chris Brightling; Jane Davies; Ratko Djukanovic; Liam G Heaney; Tracy Hussell; Stefan J Marciniak; Lorcan McGarvey; Joanna C Porter; Thomas Wilkinson; Ling-Pei Ho
Journal:  Lancet Respir Med       Date:  2022-06-13       Impact factor: 102.642
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.